These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial. Lanctôt KL; Rivet L; Tumati S; Perin J; Sankhe K; Vieira D; Mintzer J; Rosenberg PB; Shade D; Lerner AJ; Padala PR; Brawman-Mintzer O; van Dyck CH; Porsteinsson AP; Craft S; Levey AI; Padala KP; Herrmann N Am J Geriatr Psychiatry; 2023 Dec; 31(12):1077-1087. PubMed ID: 37385898 [TBL] [Abstract][Full Text] [Related]
8. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia. Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of methylphenidate for the treatment of apathy in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled studies. Lee CW; Chen JY; Ko CC; Chuang MH; Tsai WW; Sun CK; Hung KC Psychopharmacology (Berl); 2022 Dec; 239(12):3743-3753. PubMed ID: 36243827 [TBL] [Abstract][Full Text] [Related]
11. Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2). Lanctôt KL; Chen C; Mah E; Kiss A; Li A; Shade D; Scherer RW; Vieira D; Coulibaly H; Rosenberg PB; Lerner AJ; Padala PR; Brawman-Mintzer O; van Dyck CH; Porsteinsson AP; Craft S; Levey A; Burke WJ; Mintzer J; Herrmann N Int Psychogeriatr; 2023 Nov; 35(11):664-672. PubMed ID: 37066690 [TBL] [Abstract][Full Text] [Related]
12. Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study. Goukasian N; Hwang KS; Romero T; Grotts J; Do TM; Groh JR; Bateman DR; Apostolova LG BMJ Open; 2019 Dec; 9(12):e031947. PubMed ID: 31857304 [TBL] [Abstract][Full Text] [Related]
13. Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial. Padala PR; Padala KP; Lensing SY; Ramirez D; Monga V; Bopp MM; Roberson PK; Dennis RA; Petty F; Sullivan DH; Burke WJ Am J Psychiatry; 2018 Feb; 175(2):159-168. PubMed ID: 28945120 [TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress. Fonseca LM; Mattar GP; Haddad GG; Burduli E; McPherson SM; Guilhoto LMFF; Yassuda MS; Busatto GF; Bottino CMC; Hoexter MQ; Chaytor NS J Alzheimers Dis; 2021; 81(1):137-154. PubMed ID: 33749644 [TBL] [Abstract][Full Text] [Related]
15. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study. Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961 [TBL] [Abstract][Full Text] [Related]
16. Methylphenidate and Other Pharmacologic Treatments for Apathy in Alzheimer's Disease. Andrade C J Clin Psychiatry; 2022 Feb; 83(1):. PubMed ID: 35120284 [TBL] [Abstract][Full Text] [Related]
17. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study. Vik-Mo AO; Giil LM; Ballard C; Aarsland D Int J Geriatr Psychiatry; 2018 Oct; 33(10):1361-1369. PubMed ID: 29979473 [TBL] [Abstract][Full Text] [Related]
18. Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial. Lanctôt KL; Chau SA; Herrmann N; Drye LT; Rosenberg PB; Scherer RW; Black SE; Vaidya V; Bachman DL; Mintzer JE Int Psychogeriatr; 2014 Feb; 26(2):239-46. PubMed ID: 24169147 [TBL] [Abstract][Full Text] [Related]
19. Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study. Nagata T; Nakajima S; Shinagawa S; Plitman E; Graff-Guerrero A; Mimura M; Nakayama K Int J Geriatr Psychiatry; 2017 Dec; 32(12):1264-1271. PubMed ID: 27714849 [TBL] [Abstract][Full Text] [Related]
20. Association of caregiver demographic variables with neuropsychiatric symptoms in Alzheimer's disease patients for distress on the Neuropsychiatric Inventory (NPI). Godinho C; Camozzato A; Kochhann R; Chaves MLF Dement Neuropsychol; 2008; 2(3):211-216. PubMed ID: 29213573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]